New Drugs Lift Novartis Profit 12%

July 19, 2011
Sales of recently launched products contributed $3.8 billion to overall group sales, which were up 27% at $14.9 billion.

Swiss pharmaceutical company Novartis said on July 19 that its second quarter net profit rose 12% to $2.72 billion.

"Our recently launched products continue to transform our portfolio, our new products grew 46% and represent now 25% of our group sales in Q2," said Joseph Jimenez, Novartis chief executive officer.

Sales of recently launched products contributed $3.8 billion to overall group sales, which were up 27% at $14.9 billion.

Currency impact lent an 8% boost to overall revenues.

For the rest of the year, the group said it was maintaining its forecast for sales growth reaching "around the double-digit mark.

Copyright Agence France-Presse, 2011

About the Author

Agence France-Presse

Copyright Agence France-Presse, 2002-2017. AFP text, photos, graphics and logos shall not be reproduced, published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP shall not be held liable for any delays, inaccuracies, errors or omissions in any AFP content, or for any actions taken in consequence.

Sponsored Recommendations

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!